| Date Filed | Type | Description |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/02/2016 |
4
| Wiezorek Jeffrey (SVP Clinical Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 1,238 shares
@ $58.17, valued at
$72k
Sold 262 shares
@ $58.58, valued at
$15.3k
Exercised 1,500 options to buy
@ $6.89, valued at
$10.3k
|
|
| 08/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2016 |
4
| Wiezorek Jeffrey (SVP Clinical Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 1,500 shares
@ $50, valued at
$75k
Sold 1,325 shares
@ $51.22, valued at
$67.9k
Sold 175 shares
@ $51.9, valued at
$9.1k
Exercised 1,500 options to buy
@ $6.89, valued at
$10.3k
Exercised 1,500 options to buy
@ $6.89, valued at
$10.3k
|
|
| 03/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/18/2016 |
4
| Wiezorek Jeffrey (SVP Clinical Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 7,612 shares
@ $44, valued at
$334.9k
Sold 1,388 shares
@ $44.47, valued at
$61.7k
Granted 25,000 options to buy
@ $6.89, valued at
$172.3k
Exercised 9,000 options to buy
@ $6.89, valued at
$62k
|
|